QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causing mechanisms.

Biotechnology

QurAlis

Kasper Roet

Emma Bowden

Bryan Boggs

Kevin Eggan

Abi Foster

Barry F.

Sudhir Agrawal

Hagen Cramer

Vikas Sharma

Daniel Elbaum

Shirley Lasch

Chris Thomajan

Angela Genge

The Research and Development Team at QurAlis is dedicated to advancing the understanding and treatment of ALS by investigating the underlying mechanisms of the disease. Comprising a diverse group of scientific experts, the team collaborates to develop targeted therapeutics, design and conduct experiments, and analyze data to identify potential pathways for intervention. Their work aims to translate innovative research into precision medicine solutions that improve the lives of ALS patients.

Research and Development Team

Leadership Team

Finance and Administration Team

Research and Development Team

About

Team members

Other teams at QurAlis

Leadership Team

Finance and Administration Team